Allogene Therapeutics (ALLO) Other Working Capital Changes (2018 - 2026)
Allogene Therapeutics (ALLO) reported Other Working Capital Changes of $316000.0 for Q1 2026, up 117.24% on a YoY basis from $145461.6 in Q1 2025, and down 95.32% sequentially from $6.7 million in Q4 2025.
Allogene Therapeutics (ALLO) Other Working Capital Changes (2018 - 2026) Analysis & Trends
Allogene Therapeutics (ALLO) has 9 years of Other Working Capital Changes data on file, last reported at $316000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes rose 117.24% year-over-year to $316000.0; the trailing twelve-month figure through Mar 2026 stood at $3.3 million (up 140.3% YoY), and the FY2025 full-year result was $1.1 million, up 118.0% from the prior year.
- Other Working Capital Changes retreated to $316000.0 in Q1 2026, from $6.7 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $6.7 million in Q1 2022 to a low of -$5.7 million in Q3 2022.
- A 5-year average of -$440058.8 and a median of -$986000.0 in 2025 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes tumbled 269250.0% in 2023 and jumped 480.01% in 2025, its largest moves.
- Tracing ALLO's Other Working Capital Changes over 5 years: stood at -$2000.0 in 2022, then plunged by 269250.0% to -$5.4 million in 2023, then soared by 67.03% to -$1.8 million in 2024, then jumped by 480.01% to $6.7 million in 2025, then tumbled by 95.32% to $316000.0 in 2026.
- Business Quant data shows ALLO's Other Working Capital Changes at $316000.0 in Q1 2026, $6.7 million in Q4 2025, and -$1.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Allogene Therapeutics | 437.33 Mn | 437.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 316,000.00 |
| Mar 31, 2026 | 316,000.00 |
| Mar 31, 2026 | 316,000.00 |
| Dec 31, 2025 | 6.75 Mn |
| Dec 31, 2025 | 6.75 Mn |
| Dec 31, 2025 | 6.75 Mn |
| Sep 30, 2025 | -1.86 Mn |
| Sep 30, 2025 | -1.86 Mn |
| Sep 30, 2025 | -1.86 Mn |
| Jun 30, 2025 | -1.93 Mn |
| Jun 30, 2025 | -1.93 Mn |
| Jun 30, 2025 | -1.93 Mn |
| Mar 31, 2025 | -1.83 Mn |
| Mar 31, 2025 | -1.83 Mn |
| Mar 31, 2025 | -1.83 Mn |
| Dec 31, 2024 | -1.78 Mn |
| Dec 31, 2024 | -1.78 Mn |
| Dec 31, 2024 | -1.78 Mn |
| Sep 30, 2024 | -4.58 Mn |
| Sep 30, 2024 | -4.58 Mn |